ORAGENICS, INC. Disposal Group, Including Discontinued Operation, Revenue
ORAGENICS, INC. (OGEN) reported Disposal Group, Including Discontinued Operation, Revenue of $0 for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2017-05-15
- ORAGENICS, INC. disposal group, including discontinued operation, revenue for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- ORAGENICS, INC. disposal group, including discontinued operation, revenue for the quarter ending 2016-12-31 was $11.10K.
- ORAGENICS, INC. disposal group, including discontinued operation, revenue for the quarter ending 2016-09-30 was -$109.00, a 100.03% decline year-over-year.
- ORAGENICS, INC. disposal group, including discontinued operation, revenue for the quarter ending 2016-06-30 was $190.80K, a 21.17% decline year-over-year.
- ORAGENICS, INC. disposal group, including discontinued operation, revenue for fiscal 2016 was $464.05K.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month |
|---|---|---|---|---|
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | $11.10K derived: sum of 2 quarters · filed 2017-05-15 | $10.99K derived: sum of 3 quarters · filed 2017-05-15 | $201.79K derived: sum of 4 quarters · filed 2017-05-15 |
| 2016-12-31 | $11.10K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $10.99K derived: sum of 2 quarters · filed 2017-02-27 | $201.79K derived: sum of 3 quarters · filed 2017-02-27 | $464.05K 10-K · filed 2017-02-27 |
| 2016-09-30 | -$109.00 10-Q · filed 2016-11-14 | $190.69K derived: sum of 2 quarters · filed 2016-11-14 | $452.94K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $190.80K 10-Q · filed 2016-08-15 | $453.05K 10-Q · filed 2016-08-15 | ||
| 2016-03-31 | $262.26K derived: 10-K 12 month − 3 quarters · filed 2017-02-27 | |||
| 2015-09-30 | $329.80K 10-Q · filed 2016-11-14 | $571.83K derived: sum of 2 quarters · filed 2016-11-14 | $935.61K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $242.04K 10-Q · filed 2016-08-15 | $605.81K 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |